| Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech |
NOT-NS-23-002 |
|
|
06/21/2024 |
|
| Consortium for Palliative Care Research Across the Lifespan |
RFA-AG-25-002 (U54 Clinical Trial Optional) |
U54 |
Clinical Trial Optional |
07/03/2024 |
Brennan Streck, Ph.D., R.N., M.P.H. |
| Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity |
PAR-22-092 (R01 - Clinical Trials Optional) |
R01 |
|
09/08/2024 |
Ellen Richmond, M.S., G.N.P.-B.C. |
| Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity |
NOT-CA-22-001 |
|
|
11/06/2024 |
|
| HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment |
RFA-NS-22-034 (R01 Clinical Trial Not Allowed) |
R01 |
Clinical Trial Not Allowed |
12/07/2024 |
Rachel Altshuler, Ph.D. |
| Notice of Intent to Publish a Funding Opportunity Announcement for Consortium for Palliative Care Research Across the Lifespan |
NOT-AG-23-050 (U54 Clinical Trial Required) |
U54 |
Clinical Trial Required |
12/31/2024 |
Brennan Streck, Ph.D., R.N., M.P.H. |
| Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities |
PAR-22-064 (R01 Clinical Trial Optional) |
R01 |
Clinical Trial Optional |
01/08/2025 |
Ellen Richmond, M.S., G.N.P.-B.C. |
| HEAL Initiative: Understanding Individual Differences in Human Pain Conditions |
RFA-NS-24-021 (R01 - Clinical Trial Optional) |
R01 |
Clinical Trial Optional |
02/07/2025 |
Rachel Altshuler, Ph.D. |
| HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices |
RFA-NS-23-028 (RM1 Clinical Trial Optional) |
RM1 |
Clinical Trial Optional |
06/10/2025 |
Rachel Altshuler, Ph.D. |
| HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices |
RFA-NS-23-003 (RM1 Clinical Trial Optional) |
RM1 |
Clinical Trial Optional |
06/10/2025 |
|